Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
© 2016 The Korean Society of Pathologists/The Korean Society for Cytopathology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
References | No. of cases | Age (median, yr) | Male:Femlae | Extrarenal lesion | Serum IgG (median, mg/dL) | Serum lgG4 (median, mg/dL) | SCr at biopsy (mean) | Elevated Cr (>1.2 mg/dL) | ANA (+) | RF (+) | Proteinuria (> 1 g/day) | Hematuria | Renal biopsy finding |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Saeki et al. [7] | 23 | 40-83 (64) | 20:3 | Sa (19), LN (10), Pa (9), La (7), Lu (6), Li (1), Pr (1) | 2,721-8,841 (4,387) | 305-4,630 (1,330) | 0.67-6.87 (1.98) | 13/23 | 16/23 | 7/18 | 2/23 | 8/23 | TIN (23/23), MGN (1/23), mild MPGN (3/23), focal segmental EC (1/23) |
Raissian et al. [8] | 35 | 20-84 (67) | 30:5 | Sa (6), LN (8), Pa (15), La (1), Lu (8), Li (7), RP(3) | - | - | 0.9-9.0 (3.57) | 27/35 | 10/32 | - | 8/27 | 6/27 | TIN (35/35), MGN (2/35), many eosinophils (4/35) |
Kawano et al. [28] | 20 | 55-83 (70) | 18:2 | Jo (1), La (2), Li (1), LN (5), Lu (6), Ne (1), Pa (7), Pr (2), RP (1), Sa (12) | 1,679-5,380 (3,596) | 408-1,860 (828) | 0.59-7.26 (1.36) | 12/20 | - | - | 2/15 | - | TIN (20/20), MPGN (1), IgAN (1), EC (2), HSPN (2), MGN (3) |
Yamaguchi et al. [13] | 16 | 45-78 (62) | 12:4 | Pa (8), Sa (7), RP (1), Lu (1), Li (1) | 1,569-6,328 (3,604) | 142-2,120 (958) | 0.84-6.17 (1.6) | 12/16 | - | - | 3/11 | - | TIN (16/16), MGN (2) |
SCr, serum creatinine; Cr, creatinine; ANA, antinuclear antibodies; RF, rheumatoid factor; Sa, salivary gland; LN, lymph node; Pa, pancreas; La, lacrimal gland; Lu, lung; Li, liver; Pr, prostate; TIN, tubulointerstitial nephritis; MGN, membranous nephropathy; MPGN, membranoproliferative glomerulonephritis; EC, endocapillary hypercellularity; RP, retroperitoneum; Jo, joint; Ne, nerve; IgAN, IgA nephropathy; HSPN, Henoch-Schönlein purpura nephritis.
Age | Sex | Serum IgG (mg/dL) | Serum IgG4 (mg/dL) | Antibody | SCr (mg/dL) | Proteinuria | Systemic complications | IgG4/HPF | IgG4/IgG (%) | IF | EM | Diagnosis of kidney biopsy | Reference | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
lgG4-RD and Sjogren's syndrome | 49 | F | 6,000 | 2,790 | Anti-SS-A (1:16) | - | - | Chronic hepatitis (3), portal hypertension (2), retroperitoneal ficrosis (1), renal involve (1) | 21.7 | 42.1 | - | - | - | Yamamoto et al. [47] |
43 | F | 1,898 | 188 | Anti-SS-A (1:16) | - | - | - | - | - | - | - | |||
48 | F | 3,009 | 768 | Anti-SS-A (1:4) | . | . | 11.3 | 23.5 | . | . | . | |||
56 | F | 1,890 | 694 | Anti-SS-A (1:16) | - | - | 9.7 | 19.4 | - | - | - | |||
59 | M | 1,880 | 339 | Anti-SS-A (1:64) | - | - | - | - | - | - | - | |||
73 | M | 1,912 | 374 | Anti-SS-A (1:16) | - | - | 6.7 | 21.3 | - | - | - | |||
61 | M | 2,558 | 774 | Anti-SS-A (1:16) | - | - | 14.7 | 33.4 | - | - | - | |||
lgG4-RD and Sjogren's syndrome | 62 | F | 8,478 | 647 | ANA (1:10,240, homogeneous), anti-SS-A (+), anti-SS-B (+) | 0.92 | 0.82 g/gCr | General malaise, dry mouth, Raynaud’s phenomenon, anemia, lower extremity weakness, hypergammaglobulinemia | 15 | - | No immunoglobulin or complement deposition | - | Chronic plasma cell-rich TIN | Kawano et al. [45] |
lgG4-RD and Churg-Strauss Syndrome | 68 | F | 1,997 | 275 | ANCA (–), anti–SS-A (–), RF (+) | 0.9 | 1.2 g/day | Asthma, multifocal pulmonary infiltrates, marked eosinophilia, a rash on feet, right median nerve paralysis, salivary gland swelling | - | 10 | IgG, C3 (granular, capillary), lgG1, lgG4 (+) | Electron-dense to electron-lucent subepithelial deposits in glomerular capillary walls | MGN (stage lll-IV) with eosinophil-rich TIN | Ayuzawa et al. [53] |
IgG4-RD and Lupus nephritis | 71 | F | lgG1:1,230, lgG2:735, lgG3:418 | 37.1 | ANA (1.320 homogeneous) | 9.65 | 2.6 g/day | Abdominal pain, vomiting, diarrhea, epigastric tenderness, bilateral lower extremity pitting edema, marked leukocytosis, hypoalbuminemia, no skin changes | 13 | - | IgG, K, L (2+, granular, mesangial), IgM, IgA, C3 (1+, granular, mesangial) | Small paramesangial and scattered small electron dense to electron lucent subepithelial and intramembranous deposits | IgG4-related TIN with MGN, and/or lupus membranous nephritis with TIN | Zaarour et al. [54] |
ANCA (–), anti–SS-A (–), anti–SS-B (–), anti-dsDNS (–), anti-Sm (–), anti-GBM (–) |
IgG4-TIN, tubulointerstitial nephritis with dominant IgG4-positive cell infiltrate; SCr, serum creatinine; HPF, high-power field; IF, immunofluorescence; EM, electron microscopy; IgG4-RD, IgG4-related disease; ANA, antinuclear antibodies; TIN, tubulointerstitial nephritis; ANCA, anti-neutrophil cytoplasmic antibody; RF, rheumatoid factor; MGN, membranous nephropathy; GBM, glomerular basement membrane; K. kappa light chain; L, lambda light chain.
References | No. of cases | Age (median, yr) | Male:Femlae | Extrarenal lesion | Serum IgG (median, mg/dL) | Serum lgG4 (median, mg/dL) | SCr at biopsy (mean) | Elevated Cr (>1.2 mg/dL) | ANA (+) | RF (+) | Proteinuria (> 1 g/day) | Hematuria | Renal biopsy finding |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Saeki et al. [7] | 23 | 40-83 (64) | 20:3 | Sa (19), LN (10), Pa (9), La (7), Lu (6), Li (1), Pr (1) | 2,721-8,841 (4,387) | 305-4,630 (1,330) | 0.67-6.87 (1.98) | 13/23 | 16/23 | 7/18 | 2/23 | 8/23 | TIN (23/23), MGN (1/23), mild MPGN (3/23), focal segmental EC (1/23) |
Raissian et al. [8] | 35 | 20-84 (67) | 30:5 | Sa (6), LN (8), Pa (15), La (1), Lu (8), Li (7), RP(3) | - | - | 0.9-9.0 (3.57) | 27/35 | 10/32 | - | 8/27 | 6/27 | TIN (35/35), MGN (2/35), many eosinophils (4/35) |
Kawano et al. [28] | 20 | 55-83 (70) | 18:2 | Jo (1), La (2), Li (1), LN (5), Lu (6), Ne (1), Pa (7), Pr (2), RP (1), Sa (12) | 1,679-5,380 (3,596) | 408-1,860 (828) | 0.59-7.26 (1.36) | 12/20 | - | - | 2/15 | - | TIN (20/20), MPGN (1), IgAN (1), EC (2), HSPN (2), MGN (3) |
Yamaguchi et al. [13] | 16 | 45-78 (62) | 12:4 | Pa (8), Sa (7), RP (1), Lu (1), Li (1) | 1,569-6,328 (3,604) | 142-2,120 (958) | 0.84-6.17 (1.6) | 12/16 | - | - | 3/11 | - | TIN (16/16), MGN (2) |
Age | Sex | Serum IgG (mg/dL) | Serum IgG4 (mg/dL) | Antibody | SCr (mg/dL) | Proteinuria | Systemic complications | IgG4/HPF | IgG4/IgG (%) | IF | EM | Diagnosis of kidney biopsy | Reference | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
lgG4-RD and Sjogren's syndrome | 49 | F | 6,000 | 2,790 | Anti-SS-A (1:16) | - | - | Chronic hepatitis (3), portal hypertension (2), retroperitoneal ficrosis (1), renal involve (1) | 21.7 | 42.1 | - | - | - | Yamamoto et al. [47] |
43 | F | 1,898 | 188 | Anti-SS-A (1:16) | - | - | - | - | - | - | - | |||
48 | F | 3,009 | 768 | Anti-SS-A (1:4) | . | . | 11.3 | 23.5 | . | . | . | |||
56 | F | 1,890 | 694 | Anti-SS-A (1:16) | - | - | 9.7 | 19.4 | - | - | - | |||
59 | M | 1,880 | 339 | Anti-SS-A (1:64) | - | - | - | - | - | - | - | |||
73 | M | 1,912 | 374 | Anti-SS-A (1:16) | - | - | 6.7 | 21.3 | - | - | - | |||
61 | M | 2,558 | 774 | Anti-SS-A (1:16) | - | - | 14.7 | 33.4 | - | - | - | |||
lgG4-RD and Sjogren's syndrome | 62 | F | 8,478 | 647 | ANA (1:10,240, homogeneous), anti-SS-A (+), anti-SS-B (+) | 0.92 | 0.82 g/gCr | General malaise, dry mouth, Raynaud’s phenomenon, anemia, lower extremity weakness, hypergammaglobulinemia | 15 | - | No immunoglobulin or complement deposition | - | Chronic plasma cell-rich TIN | Kawano et al. [45] |
lgG4-RD and Churg-Strauss Syndrome | 68 | F | 1,997 | 275 | ANCA (–), anti–SS-A (–), RF (+) | 0.9 | 1.2 g/day | Asthma, multifocal pulmonary infiltrates, marked eosinophilia, a rash on feet, right median nerve paralysis, salivary gland swelling | - | 10 | IgG, C3 (granular, capillary), lgG1, lgG4 (+) | Electron-dense to electron-lucent subepithelial deposits in glomerular capillary walls | MGN (stage lll-IV) with eosinophil-rich TIN | Ayuzawa et al. [53] |
IgG4-RD and Lupus nephritis | 71 | F | lgG1:1,230, lgG2:735, lgG3:418 | 37.1 | ANA (1.320 homogeneous) | 9.65 | 2.6 g/day | Abdominal pain, vomiting, diarrhea, epigastric tenderness, bilateral lower extremity pitting edema, marked leukocytosis, hypoalbuminemia, no skin changes | 13 | - | IgG, K, L (2+, granular, mesangial), IgM, IgA, C3 (1+, granular, mesangial) | Small paramesangial and scattered small electron dense to electron lucent subepithelial and intramembranous deposits | IgG4-related TIN with MGN, and/or lupus membranous nephritis with TIN | Zaarour et al. [54] |
ANCA (–), anti–SS-A (–), anti–SS-B (–), anti-dsDNS (–), anti-Sm (–), anti-GBM (–) |
SCr, serum creatinine; Cr, creatinine; ANA, antinuclear antibodies; RF, rheumatoid factor; Sa, salivary gland; LN, lymph node; Pa, pancreas; La, lacrimal gland; Lu, lung; Li, liver; Pr, prostate; TIN, tubulointerstitial nephritis; MGN, membranous nephropathy; MPGN, membranoproliferative glomerulonephritis; EC, endocapillary hypercellularity; RP, retroperitoneum; Jo, joint; Ne, nerve; IgAN, IgA nephropathy; HSPN, Henoch-Schönlein purpura nephritis.
IgG4-TIN, tubulointerstitial nephritis with dominant IgG4-positive cell infiltrate; SCr, serum creatinine; HPF, high-power field; IF, immunofluorescence; EM, electron microscopy; IgG4-RD, IgG4-related disease; ANA, antinuclear antibodies; TIN, tubulointerstitial nephritis; ANCA, anti-neutrophil cytoplasmic antibody; RF, rheumatoid factor; MGN, membranous nephropathy; GBM, glomerular basement membrane; K. kappa light chain; L, lambda light chain.